发明名称 |
TREATMENT OF AUTOIMMUNE DISEASE BY ANTI-CCL20 ANTIBODY |
摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a pharmaceutical which inhibits the CCL20 function expressed in the autoimmune disease site and is effective for the autoimmune disease. <P>SOLUTION: The autoimmune disease treating agent comprises a monoclonal antibody responsive to CCL20 or its fragment as an active ingredient. <P>COPYRIGHT: (C)2009,JPO&INPIT</p> |
申请公布号 |
JP2009096716(A) |
申请公布日期 |
2009.05.07 |
申请号 |
JP20060011525 |
申请日期 |
2006.01.19 |
申请人 |
EISAI R & D MANAGEMENT CO LTD |
发明人 |
MURAMOTO KENZO;HORIZOE TATSUO;IMAI TOSHIO;NISHIMURA MIYUKI;MIZUNO KEIKO |
分类号 |
A61K39/395;A61P19/02;A61P19/10;A61P29/00;A61P37/06;C12N5/10;C12N15/09;C12Q1/02;G01N33/15;G01N33/50 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|